Fischer Medical Ventures enterprise value

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026
1,626—
11.911.9
0.80.8
72.472.4
1,688—
60.560.5
₹25.79—
458458
15.8%15.8%
0.04×—
4.60×—
33.70×—
36.29×—
Reference items — trailing FY values
367309
50.143.1
46.540.1
—−101
−103−103
—−103
—1.3
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

FISCHER₹24.85

Fischer Medical Ventures Limited

· Pharma & Health
₹ CrorePeersTARSONSLAXMIDENTLFABTECHGKBMcap ₹1,626 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Current/LTM
TTM · last close
Market Capitalization—1,626.5
- Cash, Equiv & ST Investments11.911.9
+ Minority Interest0.80.8
+ Total Debt72.472.4
Enterprise Value—1,687.7
Net Debt (memo)60.560.5
EV per Share—25.79
Total Capital457.5457.5
Total Debt/Total Capital15.8215.82
Total Debt/EV—0.04
EV/Sales—4.60
EV/EBITDA—33.70
EV/EBIT—36.29
Reference Items — Trailing FY Values
Sales308.6367.1
EBITDA43.150.1
EBIT40.146.5
Operating Cash Flow-101.3—
Free Cash Flow-102.6-102.6
FCFF (free cash flow to the firm)-103.4—
Capital Expenditure1.3—
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.